Approximately 60% of T-ALL cases also have mutations that augment expression of the transcription factors T acute lymphoblastic leukemia antigen 1 (TAL1), also called Stem Cell Leukemia (SCL), and lymphocytic leukemia antigen 1 (LYL1) (9). This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.